{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:50:21Z","timestamp":1792018221188,"version":"4.4.0"},"update-to":[{"DOI":"10.1371\/journal.ppat.1009215","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:00:00Z","timestamp":1611619200000}}],"reference-count":259,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>Poxvirus systems have been extensively used as vaccine vectors. Herein a RNA-Seq analysis of intramuscular injection sites provided detailed insights into host innate immune responses, as well as expression of vector and recombinant immunogen genes, after vaccination with a new multiplication defective, vaccinia-based vector, Sementis Copenhagen Vector. Chikungunya and Zika virus immunogen mRNA and protein expression was associated with necrosing skeletal muscle cells surrounded by mixed cellular infiltrates. The multiple adjuvant signatures at 12 hours post-vaccination were dominated by TLR3, 4 and 9, STING, MAVS, PKR and the inflammasome. Th1 cytokine signatures were dominated by IFN\u03b3, TNF and IL1\u03b2, and chemokine signatures by CCL5 and CXCL12. Multiple signatures associated with dendritic cell stimulation were evident. By day seven, vaccine transcripts were absent, and cell death, neutrophil, macrophage and inflammation annotations had abated. No compelling arthritis signatures were identified. Such injection site vaccinology approaches should inform refinements in poxvirus-based vector design.<\/jats:p>","DOI":"10.1371\/journal.ppat.1009215","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T14:33:17Z","timestamp":1610548397000},"page":"e1009215","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Injection site vaccinology of a recombinant vaccinia-based vector reveals diverse innate immune signatures"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6104-4531","authenticated-orcid":true,"given":"Jessamine E.","family":"Hazlewood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3032-8360","authenticated-orcid":true,"given":"Troy","family":"Dumenil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuy T.","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3258-0508","authenticated-orcid":true,"given":"Andrii","family":"Slonchak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6562-1383","authenticated-orcid":true,"given":"Stephen H.","family":"Kazakoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6121-4019","authenticated-orcid":true,"given":"Ann-Marie","family":"Patch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3531-4363","authenticated-orcid":true,"given":"Lesley-Ann","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2779-9962","authenticated-orcid":true,"given":"Paul M.","family":"Howley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6272-2565","authenticated-orcid":true,"given":"Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Hayball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2203-217X","authenticated-orcid":true,"given":"Kexin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7248-0101","authenticated-orcid":true,"given":"Daniel J.","family":"Rawle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7312-8767","authenticated-orcid":true,"given":"Natalie A.","family":"Prow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8986-9025","authenticated-orcid":true,"given":"Andreas","family":"Suhrbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"key":"ppat.1009215.ref001","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1080\/14760584.2018.1522255","article-title":"Poxvirus-based vector systems and the potential for multi-valent and multi-pathogen vaccines.","volume":"17","author":"NA Prow","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"ppat.1009215.ref002","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S1473-3099(20)30248-6","article-title":"Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial.","volume":"20","author":"T Koch","year":"2020","journal-title":"Lancet Infect Dis."},{"key":"ppat.1009215.ref003","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1073\/pnas.2001335117","article-title":"A vital gene for modified vaccinia virus Ankara replication in human cells","volume":"117","author":"G Sutter","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1009215.ref004","doi-asserted-by":"crossref","first-page":"e737","DOI":"10.1016\/S2352-3018(19)30262-0","article-title":"Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial.","volume":"6","author":"G Pantaleo","year":"2019","journal-title":"Lancet HIV."},{"key":"ppat.1009215.ref005","doi-asserted-by":"crossref","first-page":"e1003038","DOI":"10.1371\/journal.pmed.1003038","article-title":"Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120\/MF59 vaccines.","volume":"17","author":"F Laher","year":"2020","journal-title":"PLoS Med."},{"key":"ppat.1009215.ref006","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1158\/1078-0432.CCR-19-0183","article-title":"A Phase I Dose-Escalation Trial of BN-CV301, a Recombinant Poxviral Vaccine Targeting MUC1 and CEA with Costimulatory Molecules","volume":"25","author":"ME Gatti-Mays","year":"2019","journal-title":"Clin Cancer Res"},{"key":"ppat.1009215.ref007","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7883\/yoken.JJID.2017.458","article-title":"A Novel System for Constructing a Recombinant Highly-Attenuated Vaccinia Virus Strain (LC16m8) Expressing Foreign Genes and Its Application for the Generation of LC16m8-Based Vaccines against Herpes Simplex Virus 2.","volume":"71","author":"N Omura","year":"2018","journal-title":"Jpn J Infect Dis"},{"key":"ppat.1009215.ref008","doi-asserted-by":"crossref","first-page":"7323","DOI":"10.1016\/j.vaccine.2020.09.037","article-title":"Prospective safety surveillance study of ACAM2000 smallpox vaccine in deploying military personnel","volume":"38","author":"DJ Faix","year":"2020","journal-title":"Vaccine"},{"key":"ppat.1009215.ref009","doi-asserted-by":"crossref","first-page":"e0005958","DOI":"10.1371\/journal.pntd.0005958","article-title":"Protection of bats (Eptesicus fuscus) against rabies following topical or oronasal exposure to a recombinant raccoon poxvirus vaccine.","volume":"11","author":"B Stading","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"ppat.1009215.ref010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/02648725.2018.1471643","article-title":"Vaccinia-based vaccines to biothreat and emerging viruses.","volume":"34","author":"LP Nagata","year":"2018","journal-title":"Biotechnol Genet Eng Rev"},{"key":"ppat.1009215.ref011","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1817307","article-title":"Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox","volume":"381","author":"PR Pittman","year":"2019","journal-title":"N Engl J Med"},{"key":"ppat.1009215.ref012","doi-asserted-by":"crossref","first-page":"1829829","DOI":"10.1080\/16549716.2020.1829829","article-title":"Implementation of accelerated research: strategies for implementation as applied in a phase 1 Ad26.ZEBOV, MVA-BN-Filo two-dose Ebola vaccine clinical trial in Uganda.","volume":"13","author":"J Kitonsa","year":"2020","journal-title":"Glob Health Action."},{"key":"ppat.1009215.ref013","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3390\/v10030101","article-title":"Modulating Vaccinia Virus Immunomodulators to Improve Immunological Memory.","volume":"10","author":"JD Albarnaz","year":"2018","journal-title":"Viruses."},{"key":"ppat.1009215.ref014","first-page":"e01648","article-title":"Novel Modified Vaccinia Virus Ankara Vector Expressing Anti-apoptotic Gene B13R Delays Apoptosis and Enhances Humoral Responses","volume":"93","author":"LS Chea","year":"2019","journal-title":"J Virol"},{"key":"ppat.1009215.ref015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2174\/18715206113136660376","article-title":"Poxvirus-based vaccines for cancer immunotherapy: new insights from combined cytokines\/co-stimulatory molecules delivery and \"uncommon\" strains.","volume":"14","author":"V Izzi","year":"2014","journal-title":"Anticancer Agents Med Chem."},{"key":"ppat.1009215.ref016","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3389\/fimmu.2020.00719","article-title":"Induction of Identical IgG HIV-1 Envelope Epitope Recognition Patterns After Initial HIVIS-DNA\/MVA-CMDR Immunization and a Late MVA-CMDR Boost.","volume":"11","author":"A Joachim","year":"2020","journal-title":"Front Immunol."},{"key":"ppat.1009215.ref017","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3390\/v10080414","article-title":"Removal of the C6 Vaccinia Virus Interferon-beta Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression.","volume":"10","author":"MQ Marin","year":"2018","journal-title":"Viruses"},{"key":"ppat.1009215.ref018","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/s41467-018-03662-6","article-title":"A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses","volume":"9","author":"NA Prow","year":"2018","journal-title":"Nat Commun"},{"key":"ppat.1009215.ref019","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.ymthe.2017.06.017","article-title":"Production of a chikungunya vaccine using a CHO cell and attenuated viral-based platform technology","volume":"25","author":"P Eldi","year":"2017","journal-title":"Mol Ther"},{"key":"ppat.1009215.ref020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/21645515.2018.1513439","article-title":"Poxviral promoters for improving the immunogenicity of MVA delivered vaccines.","volume":"15","author":"NK Alharbi","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"ppat.1009215.ref021","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41584-019-0276-9","article-title":"Rheumatic manifestations of chikungunya: emerging concepts and interventions.","volume":"15","author":"A Suhrbier","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"ppat.1009215.ref022","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41541-020-0191-8","article-title":"The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates","volume":"5","author":"NA Prow","year":"2020","journal-title":"NPJ Vaccines."},{"key":"ppat.1009215.ref023","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3389\/fimmu.2020.00592","article-title":"Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections.","volume":"11","author":"S Schrauf","year":"2020","journal-title":"Front Immunol."},{"key":"ppat.1009215.ref024","first-page":"90","article-title":"Moving from Empirical to Rational Vaccine Design in the 'Omics' Era.","volume":"7","author":"M Sharma","year":"2019","journal-title":"Vaccines (Basel)."},{"key":"ppat.1009215.ref025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/vaccines8010004","article-title":"Systems Vaccinology for a Live Attenuated Tularemia Vaccine Reveals Unique Transcriptional Signatures That Predict Humoral and Cellular Immune Responses.","volume":"8","author":"MS Natrajan","year":"2019","journal-title":"Vaccines (Basel)."},{"key":"ppat.1009215.ref026","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3389\/fimmu.2019.01087","article-title":"Systems Immunology Characterization of Novel Vaccine Formulations for Mycoplasma hyopneumoniae Bacterins","volume":"10","author":"AMF Matthijs","year":"2019","journal-title":"Front Immunol"},{"key":"ppat.1009215.ref027","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/21645515.2019.1697110","article-title":"Methods for predicting vaccine immunogenicity and reactogenicity","volume":"16","author":"P Gonzalez-Dias","journal-title":"Hum Vaccin Immunother. 2020"},{"key":"ppat.1009215.ref028","doi-asserted-by":"crossref","first-page":"e46149","DOI":"10.7554\/eLife.46149","article-title":"Identification of potential biomarkers of vaccine inflammation in mice","volume":"8","author":"PF McKay","year":"2019","journal-title":"Elife"},{"key":"ppat.1009215.ref029","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/14760584.2019.1604231","article-title":"Selection of adjuvants for vaccines targeting specific pathogens.","volume":"18","author":"I Sarkar","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"ppat.1009215.ref030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41541-019-0134-4","article-title":"Microprojection arrays applied to skin generate mechanical stress, induce an inflammatory transcriptome and cell death, and improve vaccine-induced immune responses.","volume":"4","author":"HI Ng","year":"2019","journal-title":"NPJ Vaccines."},{"key":"ppat.1009215.ref031","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJMoa020534","article-title":"Clinical responses to undiluted and diluted smallpox vaccine","volume":"346","author":"SE Frey","year":"2002","journal-title":"N Engl J Med"},{"key":"ppat.1009215.ref032","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1086\/508827","article-title":"Optimal bandaging of smallpox vaccination sites to decrease the potential for secondary vaccinia transmission without impairing lesion healing.","volume":"27","author":"TR Talbot","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ppat.1009215.ref033","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.vaccine.2006.10.047","article-title":"Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naive and vaccinia-immune individuals.","volume":"25","author":"J Parrino","year":"2007","journal-title":"Vaccine"},{"key":"ppat.1009215.ref034","doi-asserted-by":"crossref","first-page":"e113690","DOI":"10.1371\/journal.pone.0113690","article-title":"Vaccinia virus induces rapid necrosis in keratinocytes by a STAT3-dependent mechanism.","volume":"9","author":"Y He","year":"2014","journal-title":"PLoS One"},{"key":"ppat.1009215.ref035","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1086\/375825","article-title":"Smallpox vaccination: a review, part II. Adverse events.","volume":"37","author":"VA Fulginiti","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ppat.1009215.ref036","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.4049\/jimmunol.1500106","article-title":"IL-1R Type 1-Deficient Mice Demonstrate an Impaired Host Immune Response against Cutaneous Vaccinia Virus Infection","volume":"198","author":"T Tian","year":"2017","journal-title":"J Immunol"},{"key":"ppat.1009215.ref037","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.clim.2013.11.010","article-title":"IL-10 suppresses IL-17-mediated dermal inflammation and reduces the systemic burden of Vaccinia virus in a mouse model of eczema vaccinatum","volume":"150","author":"AR Darling","year":"2014","journal-title":"Clin Immunol"},{"key":"ppat.1009215.ref038","unstructured":"Imvanex\u2014European Medicines Agency\u2014Europa EU. ANNEX I, SUMMARY OF PRODUCT CHARACTERISTICS. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/imvanex-epar-product-information_en.pdf."},{"key":"ppat.1009215.ref039","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1016\/j.vaccine.2005.12.041","article-title":"A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S\/AS02A and MVA-CS","volume":"24","author":"SJ Dunachie","year":"2006","journal-title":"Vaccine"},{"key":"ppat.1009215.ref040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1473-3099(15)00362-X","article-title":"Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial.","volume":"16","author":"MD Tapia","year":"2016","journal-title":"Lancet Infect Dis."},{"key":"ppat.1009215.ref041","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1080\/21645515.2015.1101197","article-title":"Chikungunya vaccines in development","volume":"12","author":"M Schwameis","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"ppat.1009215.ref042","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4269\/ajtmh.2000.62.681","article-title":"Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218","volume":"62","author":"R Edelman","year":"2000","journal-title":"Am J Trop Med Hyg"},{"key":"ppat.1009215.ref043","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1016\/j.vaccine.2012.02.016","article-title":"Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination.","volume":"30","author":"C Verheust","year":"2012","journal-title":"Vaccine"},{"key":"ppat.1009215.ref044","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.4049\/jimmunol.0902187","article-title":"A physiological function of inflammation-associated SerpinB2 is regulation of adaptive immunity","volume":"184","author":"WA Schroder","year":"2010","journal-title":"J Immunol"},{"key":"ppat.1009215.ref045","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1128\/JVI.76.7.3329-3337.2002","article-title":"Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope","volume":"76","author":"LE Harrington","year":"2002","journal-title":"J Virol"},{"key":"ppat.1009215.ref046","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1517\/14712598.5.2.263","article-title":"From mice to humans\u2014murine intelligence for human CD8+ T cell vaccine design","volume":"5","author":"DC Tscharke","year":"2005","journal-title":"Expert Opin Biol Ther"},{"key":"ppat.1009215.ref047","doi-asserted-by":"crossref","first-page":"e00790","DOI":"10.1128\/mBio.00790-17","article-title":"Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral Proteins.","volume":"8","author":"LS Wyatt","year":"2017","journal-title":"mBio"},{"key":"ppat.1009215.ref048","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"JT Robinson","year":"2011","journal-title":"Nature Biotechnology"},{"key":"ppat.1009215.ref049","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1128\/JVI.64.5.2448-2451.1990","article-title":"Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus","volume":"64","author":"PL Earl","year":"1990","journal-title":"J Virol"},{"key":"ppat.1009215.ref050","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0021-9258(18)52298-5","article-title":"Cytoplasmic transcription system encoded by vaccinia virus","volume":"266","author":"B Moss","year":"1991","journal-title":"J Biol Chem"},{"key":"ppat.1009215.ref051","doi-asserted-by":"crossref","first-page":"6862","DOI":"10.1128\/JVI.03364-13","article-title":"CCR2 deficiency promotes exacerbated chronic erosive neutrophil-dominated chikungunya virus arthritis","volume":"88","author":"YS Poo","year":"2014","journal-title":"J Virol"},{"key":"ppat.1009215.ref052","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.3389\/fimmu.2019.02736","article-title":"Exacerbation of Chikungunya Virus Rheumatic Immunopathology by a High Fiber Diet and Butyrate.","volume":"10","author":"NA Prow","year":"2019","journal-title":"Front Immunol."},{"key":"ppat.1009215.ref053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-016-0001-5","article-title":"Neutrophil swarming and extracellular trap formation play a significant role in Alum adjuvant activity.","volume":"2","author":"J Stephen","year":"2017","journal-title":"NPJ Vaccines"},{"key":"ppat.1009215.ref054","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1099\/jgv.0.000002","article-title":"Monoclonal antibodies specific for the capsid protein of chikungunya virus suitable for multiple applications","volume":"96","author":"LYH Goh","year":"2015","journal-title":"Journal of General Virology"},{"key":"ppat.1009215.ref055","doi-asserted-by":"crossref","first-page":"e00095","DOI":"10.1126\/scitranslmed.aax7888","article-title":"A recombinant platform for flavivirus vaccines and diagnostics using chimeras of a new insect-specific virus.","volume":"11","author":"J Hobson-Peters","year":"2019","journal-title":"Sci Transl Med"},{"key":"ppat.1009215.ref056","doi-asserted-by":"crossref","first-page":"e0228028","DOI":"10.1371\/journal.pone.0228028","article-title":"Cytoplasmic factories, virus assembly, and DNA replication kinetics collectively constrain the formation of poxvirus recombinants","volume":"15","author":"Q Kieser","journal-title":"PLoS One. 2020"},{"key":"ppat.1009215.ref057","doi-asserted-by":"crossref","first-page":"e1005824","DOI":"10.1371\/journal.ppat.1005824","article-title":"Live-Cell Imaging of Vaccinia Virus Recombination.","volume":"12","author":"P Paszkowski","year":"2016","journal-title":"PLoS Pathog."},{"key":"ppat.1009215.ref058","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.chom.2007.08.005","article-title":"Colocalization of transcription and translation within cytoplasmic poxvirus factories coordinates viral expression and subjugates host functions","volume":"2","author":"GC Katsafanas","year":"2007","journal-title":"Cell Host Microbe"},{"key":"ppat.1009215.ref059","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/icb.2013.93","article-title":"Induction of antigen-positive cell death by the expression of perforin, but not DTa, from a DNA vaccine enhances the immune response","volume":"92","author":"T Gargett","year":"2014","journal-title":"Immunol Cell Biol"},{"key":"ppat.1009215.ref060","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/cdd.2008.68","article-title":"Atrophy and programmed cell death of skeletal muscle","volume":"15","author":"LM Schwartz","year":"2008","journal-title":"Cell Death Differ"},{"key":"ppat.1009215.ref061","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.3389\/fphys.2018.01887","article-title":"Skeletal Muscles Do Not Undergo Apoptosis During Either Atrophy or Programmed Cell Death-Revisiting the Myonuclear Domain Hypothesis.","volume":"9","author":"LM Schwartz","year":"2018","journal-title":"Front Physiol"},{"key":"ppat.1009215.ref062","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1038\/s41467-018-06057-9","article-title":"Necroptosis mediates myofibre death in dystrophin-deficient mice.","volume":"9","author":"JE Morgan","year":"2018","journal-title":"Nat Commun"},{"key":"ppat.1009215.ref063","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1172\/JCI129893","article-title":"Chikungunya virus replication in skeletal muscle cells is required for disease development","volume":"130","author":"AJ Lentscher","year":"2020","journal-title":"J Clin Invest"},{"key":"ppat.1009215.ref064","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1542\/pir.2018-0300","article-title":"Pediatric Rhabdomyolysis.","volume":"41","author":"HS Szugye","year":"2020","journal-title":"Pediatr Rev."},{"key":"ppat.1009215.ref065","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nri2779","article-title":"Phagocyte partnership during the onset and resolution of inflammation","volume":"10","author":"O Soehnlein","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"ppat.1009215.ref066","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/14712598.2019.1600669","article-title":"Poxvirus oncolytic virotherapy.","volume":"19","author":"LE Torres-Dominguez","year":"2019","journal-title":"Expert Opin Biol Ther"},{"key":"ppat.1009215.ref067","doi-asserted-by":"crossref","first-page":"e1000153","DOI":"10.1371\/journal.ppat.1000153","article-title":"Protective Effect of Toll-like Receptor 4 in Pulmonary Vaccinia Infection.","volume":"4","author":"MA Hutchens","year":"2008","journal-title":"PLOS Pathogens."},{"key":"ppat.1009215.ref068","doi-asserted-by":"crossref","first-page":"14396","DOI":"10.1128\/JVI.02082-14","article-title":"Recombinant modified vaccinia virus Ankara generating excess early double-stranded RNA transiently activates protein kinase R and triggers enhanced innate immune responses","volume":"88","author":"M Wolferstatter","year":"2014","journal-title":"J Virol"},{"key":"ppat.1009215.ref069","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4049\/jimmunol.180.1.483","article-title":"TLR3 increases disease morbidity and mortality from vaccinia infection","volume":"180","author":"M Hutchens","year":"2008","journal-title":"J Immunol"},{"key":"ppat.1009215.ref070","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1128\/JVI.02000-10","article-title":"Antigen-specific T-cell responses to a recombinant fowlpox virus are dependent on MyD88 and interleukin-18 and independent of Toll-like receptor 7 (TLR7)- and TLR9-mediated innate immune recognition.","volume":"85","author":"EL Lousberg","year":"2011","journal-title":"J Virol"},{"key":"ppat.1009215.ref071","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI33940","article-title":"Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection","volume":"118","author":"C Samuelsson","year":"2008","journal-title":"The Journal of Clinical Investigation"},{"key":"ppat.1009215.ref072","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/icb.2010.157","article-title":"Evaluating vaccinia virus cytokine co-expression in TLR GKO mice","volume":"89","author":"DB Sutherland","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"ppat.1009215.ref073","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1128\/JCM.01697-09","article-title":"GC content-based pan-pox universal PCR assays for poxvirus detection","volume":"48","author":"Y Li","year":"2010","journal-title":"J Clin Microbiol"},{"key":"ppat.1009215.ref074","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-981-10-6674-0_4","article-title":"Roles of Mitochondrial DNA Signaling in Immune Responses","volume":"1038","author":"L Wang","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"ppat.1009215.ref075","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1128\/JVI.02776-13","article-title":"MyD88-dependent immunity to a natural model of vaccinia virus infection does not involve Toll-like receptor 2","volume":"88","author":"ML Davies","year":"2014","journal-title":"J Virol"},{"key":"ppat.1009215.ref076","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1182\/blood-2008-03-148809","article-title":"A critical role for direct TLR2-MyD88 signaling in CD8 T-cell clonal expansion and memory formation following vaccinia viral infection","volume":"113","author":"M Quigley","year":"2009","journal-title":"Blood"},{"key":"ppat.1009215.ref077","doi-asserted-by":"crossref","first-page":"e1000811","DOI":"10.1371\/journal.ppat.1000811","article-title":"Direct TLR2 signaling is critical for NK cell activation and function in response to vaccinia viral infection","volume":"6","author":"J Martinez","year":"2010","journal-title":"PLoS Pathog"},{"key":"ppat.1009215.ref078","doi-asserted-by":"crossref","first-page":"10840","DOI":"10.1128\/JVI.01524-14","article-title":"Chemokine (C-C Motif) receptor 1 is required for efficient recruitment of neutrophils during respiratory infection with modified vaccinia virus Ankara.","volume":"88","author":"PJ Price","year":"2014","journal-title":"J Virol"},{"key":"ppat.1009215.ref079","doi-asserted-by":"crossref","first-page":"E139","DOI":"10.1073\/pnas.1008626107","article-title":"A major role for TLR8 in the recognition of vaccinia viral DNA by murine pDC","volume":"107","author":"S Bauer","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1009215.ref080","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1089\/jir.2019.0037","article-title":"Fueling Type I Interferonopathies: Regulation and Function of Type I Interferon Antiviral Responses","volume":"39","author":"CS Ng","year":"2019","journal-title":"J Interferon Cytokine Res"},{"key":"ppat.1009215.ref081","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.4049\/jimmunol.1002013","article-title":"Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule","volume":"185","author":"T Lysakova-Devine","year":"2010","journal-title":"J Immunol"},{"key":"ppat.1009215.ref082","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/JVI.69.2.661-668.1995","article-title":"Delay of vaccinia virus-induced apoptosis in nonpermissive Chinese hamster ovary cells by the cowpox virus CHOhr and adenovirus E1B 19K genes","volume":"69","author":"BS Ink","year":"1995","journal-title":"J Virol"},{"key":"ppat.1009215.ref083","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/JVI.70.1.165-171.1996","article-title":"Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light","volume":"70","author":"K Tsung","year":"1996","journal-title":"J Virol"},{"key":"ppat.1009215.ref084","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.virol.2011.01.034","article-title":"RNA species generated in vaccinia virus infected cells activate cell type-specific MDA5 or RIG-I dependent interferon gene transcription and PKR dependent apoptosis","volume":"413","author":"C Myskiw","year":"2011","journal-title":"Virology"},{"key":"ppat.1009215.ref085","first-page":"16","article-title":"The cytosolic DNA- and RNA-sensing pathways play important and non-redundant roles in host defense against vaccinia infection","volume":"1987","author":"L Deng","year":"2017","journal-title":"J Immunol"},{"key":"ppat.1009215.ref086","doi-asserted-by":"crossref","first-page":"10761","DOI":"10.1128\/JVI.00770-09","article-title":"Activation of MDA5 requires higher-order RNA structures generated during virus infection","volume":"83","author":"A Pichlmair","year":"2009","journal-title":"J Virol"},{"key":"ppat.1009215.ref087","doi-asserted-by":"crossref","first-page":"e1005489","DOI":"10.1371\/journal.ppat.1005489","article-title":"PKR Transduces MDA5-Dependent Signals for Type I IFN Induction.","volume":"12","author":"AM Pham","year":"2016","journal-title":"PLoS Pathog."},{"key":"ppat.1009215.ref088","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.4049\/jimmunol.1700698","article-title":"Priming and Activation of Inflammasome by Canarypox Virus Vector ALVAC via the cGAS\/IFI16-STING-Type I IFN Pathway and AIM2 Sensor","volume":"199","author":"F Liu","year":"2017","journal-title":"J Immunol"},{"key":"ppat.1009215.ref089","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2217\/fvl.13.22","article-title":"The inflammasome as a target of modulation by DNA viruses","volume":"8","author":"L Amsler","year":"2013","journal-title":"Future Virol"},{"key":"ppat.1009215.ref090","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.chom.2015.02.002","article-title":"Poxvirus decapping enzymes enhance virulence by preventing the accumulation of dsRNA and the induction of innate antiviral responses","volume":"17","author":"SW Liu","year":"2015","journal-title":"Cell Host Microbe"},{"key":"ppat.1009215.ref091","doi-asserted-by":"crossref","first-page":"14989","DOI":"10.1074\/jbc.RA118.005089","article-title":"Poxviral protein E3-altered cytokine production reveals that DExD\/H-box helicase 9 controls Toll-like receptor-stimulated immune responses","volume":"293","author":"A Dempsey","year":"2018","journal-title":"J Biol Chem"},{"key":"ppat.1009215.ref092","doi-asserted-by":"crossref","first-page":"10083","DOI":"10.1128\/JVI.00607-06","article-title":"Suppression of proinflammatory signal transduction and gene expression by the dual nucleic acid binding domains of the vaccinia virus E3L proteins.","volume":"80","author":"JO Langland","year":"2006","journal-title":"J Virol."},{"key":"ppat.1009215.ref093","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1128\/JVI.75.2.850-856.2001","article-title":"Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model","volume":"75","author":"TA Brandt","year":"2001","journal-title":"J Virol"},{"key":"ppat.1009215.ref094","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1091\/mbc.12.7.2031","article-title":"Vaccinia virus DNA replication occurs in endoplasmic reticulum-enclosed cytoplasmic mini-nuclei","volume":"12","author":"N Tolonen","year":"2001","journal-title":"Mol Biol Cell"},{"key":"ppat.1009215.ref095","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.celrep.2018.10.034","article-title":"DNA-PK Is Targeted by Multiple Vaccinia Virus Proteins to Inhibit DNA Sensing.","volume":"25","author":"SR Scutts","year":"2018","journal-title":"Cell Rep"},{"key":"ppat.1009215.ref096","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1099\/vir.0.055921-0","article-title":"Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity","volume":"94","author":"GL Smith","year":"2013","journal-title":"J Gen Virol"},{"key":"ppat.1009215.ref097","doi-asserted-by":"crossref","first-page":"7808","DOI":"10.1073\/pnas.1215995110","article-title":"Vaccinia virus F1L protein promotes virulence by inhibiting inflammasome activation","volume":"110","author":"M Gerlic","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1009215.ref098","doi-asserted-by":"crossref","first-page":"R328","DOI":"10.1016\/j.cub.2010.01.044","article-title":"Sensing and Signaling in Antiviral Innate Immunity","volume":"20","author":"LAJ O'Neill","year":"2010","journal-title":"Current Biology"},{"key":"ppat.1009215.ref099","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"T Kawasaki","year":"2014","journal-title":"Front Immunol"},{"key":"ppat.1009215.ref100","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4049\/jimmunol.1301901","article-title":"TRAF5 negatively regulates TLR signaling in B lymphocytes","volume":"192","author":"CM Buchta","year":"2014","journal-title":"J Immunol"},{"key":"ppat.1009215.ref101","doi-asserted-by":"crossref","first-page":"33858","DOI":"10.1074\/jbc.M806923200","article-title":"FLN29 deficiency reveals its negative regulatory role in the Toll-like receptor (TLR) and retinoic acid-inducible gene I (RIG-I)-like helicase signaling pathway.","volume":"283","author":"T Sanada","year":"2008","journal-title":"J Biol Chem"},{"key":"ppat.1009215.ref102","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0092-8674(02)00827-9","article-title":"IRAK-M is a negative regulator of Toll-like receptor signaling","volume":"110","author":"K Kobayashi","year":"2002","journal-title":"Cell"},{"key":"ppat.1009215.ref103","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/bjc.2014.513","article-title":"IRAK signalling in cancer","volume":"112","author":"GW Rhyasen","year":"2015","journal-title":"Br J Cancer"},{"key":"ppat.1009215.ref104","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/14728222.2019.1601702","article-title":"TANK-binding kinase 1 as a novel therapeutic target for viral diseases.","volume":"23","author":"C Zhao","year":"2019","journal-title":"Expert Opin Ther Targets"},{"key":"ppat.1009215.ref105","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/bs.aivir.2018.01.003","article-title":"How Does Vaccinia Virus Interfere With Interferon","volume":"100","author":"GL Smith","year":"2018","journal-title":"Adv Virus Res"},{"key":"ppat.1009215.ref106","doi-asserted-by":"crossref","first-page":"e1002247","DOI":"10.1371\/journal.ppat.1002247","article-title":"Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7.","volume":"7","author":"L Unterholzner","year":"2011","journal-title":"PLoS Pathog."},{"key":"ppat.1009215.ref107","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.str.2009.09.005","article-title":"Structural basis for targeting of human RNA helicase DDX3 by poxvirus protein K7","volume":"17","author":"S Oda","year":"2009","journal-title":"Structure"},{"key":"ppat.1009215.ref108","doi-asserted-by":"crossref","first-page":"e66894","DOI":"10.1371\/journal.pone.0066894","article-title":"Improving Adaptive and Memory Immune Responses of an HIV\/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling Pathways.","volume":"8","author":"J Garc\u00eda-Arriaza","year":"2013","journal-title":"PloS One."},{"key":"ppat.1009215.ref109","first-page":"184328","article-title":"The battle between virus and host: modulation of Toll-like receptor signaling pathways by virus infection.","volume":"2010","author":"S-I Yokota","year":"2010","journal-title":"Mediators of inflammation"},{"key":"ppat.1009215.ref110","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2249.2010.04196.x","article-title":"Recent insights into the role of Toll-like receptors in viral infection","volume":"161","author":"M Carty","year":"2010","journal-title":"Clinical and experimental immunology"},{"key":"ppat.1009215.ref111","doi-asserted-by":"crossref","first-page":"e1003989","DOI":"10.1371\/journal.ppat.1003989","article-title":"Modified vaccinia virus Ankara triggers type I IFN production in murine conventional dendritic cells via a cGAS\/STING-mediated cytosolic DNA-sensing pathway.","volume":"10","author":"P Dai","year":"2014","journal-title":"PLoS Pathog"},{"key":"ppat.1009215.ref112","doi-asserted-by":"crossref","first-page":"36570","DOI":"10.1074\/jbc.M400567200","article-title":"Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors","volume":"279","author":"G DiPerna","year":"2004","journal-title":"J Biol Chem"},{"key":"ppat.1009215.ref113","doi-asserted-by":"crossref","first-page":"e1002430","DOI":"10.1371\/journal.ppat.1002430","article-title":"Inhibition of Apoptosis and NF-\u03baB Activation by Vaccinia Protein N1 Occur via Distinct Binding Surfaces and Make Different Contributions to Virulence.","volume":"7","author":"C Maluquer de Motes","year":"2011","journal-title":"PLOS Pathogens."},{"key":"ppat.1009215.ref114","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1042\/BCJ20160992","article-title":"Identification of TBK1 complexes required for the phosphorylation of IRF3 and the production of interferon beta","volume":"474","author":"S Bakshi","year":"2017","journal-title":"Biochem J"},{"key":"ppat.1009215.ref115","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3389\/fimmu.2019.00325","article-title":"Regulating IRFs in IFN Driven Disease.","volume":"10","author":"CA Jefferies","year":"2019","journal-title":"Front Immunol."},{"key":"ppat.1009215.ref116","doi-asserted-by":"crossref","first-page":"e1006155","DOI":"10.1371\/journal.ppat.1006155","article-title":"RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation","volume":"13","author":"JA Wilson","year":"2017","journal-title":"PLoS Pathog"},{"key":"ppat.1009215.ref117","doi-asserted-by":"crossref","first-page":"9888","DOI":"10.1128\/JVI.00956-12","article-title":"Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock","volume":"86","author":"PA Rudd","year":"2012","journal-title":"J Virol"},{"key":"ppat.1009215.ref118","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.1016\/j.vaccine.2008.07.050","article-title":"Gene profiling analysis of ALVAC infected human monocyte derived dendritic cells","volume":"26","author":"A Harenberg","year":"2008","journal-title":"Vaccine"},{"key":"ppat.1009215.ref119","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4049\/jimmunol.1501836","article-title":"A cGAS-Independent STING\/IRF7 Pathway Mediates the Immunogenicity of DNA Vaccines","volume":"196","author":"JJ Suschak","year":"2016","journal-title":"J Immunol"},{"key":"ppat.1009215.ref120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000450705","article-title":"Deletion of Irf3 and Irf7 Genes in Mice Results in Altered Interferon Pathway Activation and Granulocyte-Dominated Inflammatory Responses to Influenza A Infection.","volume":"9","author":"B Hatesuer","year":"2017","journal-title":"J Innate Immun."},{"key":"ppat.1009215.ref121","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.4049\/jimmunol.1700782","article-title":"IFN Regulatory Factor 3 Balances Th1 and T Follicular Helper Immunity during Nonlethal Blood-Stage Plasmodium Infection","volume":"200","author":"KR James","year":"2018","journal-title":"J Immunol"},{"key":"ppat.1009215.ref122","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3389\/fimmu.2018.01135","article-title":"A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses.","volume":"9","author":"A Michalska","year":"2018","journal-title":"Front Immunol"},{"key":"ppat.1009215.ref123","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.immuni.2019.07.007","article-title":"Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III Interferons","volume":"51","author":"A Forero","year":"2019","journal-title":"Immunity"},{"key":"ppat.1009215.ref124","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/bjc.2017.389","article-title":"Interferon regulatory factor 1 priming of tumour-derived exosomes enhances the antitumour immune response","volume":"118","author":"MQ Yang","year":"2018","journal-title":"Br J Cancer"},{"key":"ppat.1009215.ref125","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00439-020-02154-2","article-title":"Role of IRF8 in immune cells functions, protection against infections, and susceptibility to inflammatory diseases","volume":"139","author":"S Salem","year":"2020","journal-title":"Hum Genet"},{"key":"ppat.1009215.ref126","doi-asserted-by":"crossref","first-page":"e00121","DOI":"10.1128\/JVI.00121-20","article-title":"IRF5 Promotes Influenza Virus-Induced Inflammatory Responses in Human Induced Pluripotent Stem Cell-Derived Myeloid Cells and Murine Models","volume":"94","author":"JL Forbester","year":"2020","journal-title":"J Virol"},{"key":"ppat.1009215.ref127","doi-asserted-by":"crossref","first-page":"15989","DOI":"10.1073\/pnas.0508327102","article-title":"Negative regulation of Toll-like-receptor signaling by IRF-4","volume":"102","author":"H Negishi","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1009215.ref128","doi-asserted-by":"crossref","first-page":"201813504","DOI":"10.1073\/pnas.1813504116","article-title":"NF-\u03baB activation is a turn on for vaccinia virus phosphoprotein A49 to turn off NF-\u03baB activation","volume":"116","author":"S Neidel","year":"2019","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"ppat.1009215.ref129","doi-asserted-by":"crossref","first-page":"10344","DOI":"10.1074\/jbc.RA118.002817","article-title":"Mechanism of vaccinia viral protein B14-mediated inhibition of I\u03baB kinase \u03b2 activation","volume":"293","author":"Q Tang","year":"2018","journal-title":"The Journal of biological chemistry"},{"key":"ppat.1009215.ref130","doi-asserted-by":"crossref","first-page":"e00051","DOI":"10.1128\/JVI.00051-19","article-title":"Vaccinia Virus BBK E3 Ligase Adaptor A55 Targets Importin-Dependent NF-kappaB Activation and Inhibits CD8(+) T-Cell Memory.","volume":"93","author":"MA Pallett","year":"2019","journal-title":"J Virol"},{"key":"ppat.1009215.ref131","doi-asserted-by":"crossref","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","article-title":"The nuclear factor NF-kappaB pathway in inflammation","volume":"1","author":"T Lawrence","year":"2009","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ppat.1009215.ref132","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/jid.2011.489","article-title":"Disruption of TNF-alpha\/TNFR1 function in resident skin cells impairs host immune response against cutaneous vaccinia virus infection","volume":"132","author":"T Tian","year":"2012","journal-title":"J Invest Dermatol"},{"key":"ppat.1009215.ref133","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.4049\/jimmunol.152.6.2652","article-title":"IFN-gamma, TNF, and IL-6 production by vaccinia virus immune spleen cells. An in vitro study","volume":"152","author":"EA Carpenter","year":"1994","journal-title":"J Immunol"},{"key":"ppat.1009215.ref134","doi-asserted-by":"crossref","first-page":"e87340","DOI":"10.1371\/journal.pone.0087340","article-title":"The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.","volume":"9","author":"M Tameris","year":"2014","journal-title":"PLoS One."},{"key":"ppat.1009215.ref135","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/all.12192","article-title":"Vaccination with recombinant modified vaccinia virus Ankara prevents the onset of intestinal allergy in mice","volume":"68","author":"C Bohnen","year":"2013","journal-title":"Allergy"},{"key":"ppat.1009215.ref136","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-981-32-9717-3_3","article-title":"The TNF-TNFR Family of Co-signal Molecules","volume":"1189","author":"T So","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"ppat.1009215.ref137","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1111\/febs.14467","article-title":"A Guide to IL-1 family cytokines in adjuvanticity.","volume":"285","author":"N Munoz-Wolf","year":"2018","journal-title":"FEBS J."},{"key":"ppat.1009215.ref138","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/eji.1830200123","article-title":"Immunodeficient mice recover from infection with vaccinia virus expressing interferon-gamma","volume":"20","author":"MR Kohonen-Corish","year":"1990","journal-title":"Eur J Immunol"},{"key":"ppat.1009215.ref139","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1023\/A:1007514424253","article-title":"Liposomes containing interferon-gamma as adjuvant in tumor cell vaccines","volume":"17","author":"ML van Slooten","year":"2000","journal-title":"Pharm Res"},{"key":"ppat.1009215.ref140","first-page":"5","article-title":"Recombinant gamma interferon is a potent adjuvant for a malaria vaccine in mice","volume":"67","author":"JH Playfair","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"ppat.1009215.ref141","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1016\/j.vaccine.2005.01.160","article-title":"An interferon gamma-gp120 fusion delivered as a DNA vaccine induces enhanced priming","volume":"23","author":"S Nimal","year":"2005","journal-title":"Vaccine"},{"key":"ppat.1009215.ref142","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1146\/annurev-immunol-032414-112134","article-title":"The immunobiology of interleukin-27","volume":"33","author":"H Yoshida","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"ppat.1009215.ref143","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0196-9781(02)00006-2","article-title":"The immunosuppressive activity of peptide fragments of vaccinia virus C10L protein and a hypothesis on the role of this protein in the viral invasion","volume":"23","author":"A Kluczyk","year":"2002","journal-title":"Peptides"},{"key":"ppat.1009215.ref144","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0092-8674(92)90274-G","article-title":"A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection","volume":"71","author":"A Alcami","year":"1992","journal-title":"Cell"},{"key":"ppat.1009215.ref145","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1089\/jir.2009.0073","article-title":"The interferon system and vaccinia virus evasion mechanisms","volume":"29","author":"B Perdiguero","year":"2009","journal-title":"J Interferon Cytokine Res"},{"key":"ppat.1009215.ref146","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1099\/0022-1317-80-4-949","article-title":"Vaccinia virus strains Lister, USSR and Evans express soluble and cell-surface tumour necrosis factor receptors","volume":"80","author":"A Alcam","year":"1999","journal-title":"J Gen Virol"},{"key":"ppat.1009215.ref147","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1099\/0022-1317-83-11-2833","article-title":"The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal modelThe nucleotide sequence of the vaccinia virus strain Western Reserve C12L gene has been deposited at GenBank and assigned accession no. AF510447","volume":"83","author":"JA Symons","year":"2002","journal-title":"J Gen Virol"},{"key":"ppat.1009215.ref148","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1128\/JVI.01617-08","article-title":"Vaccinia virus-mediated inhibition of type I interferon responses is a multifactorial process involving the soluble type I interferon receptor B18 and intracellular components","volume":"83","author":"Z Waibler","year":"2009","journal-title":"J Virol"},{"key":"ppat.1009215.ref149","doi-asserted-by":"crossref","first-page":"15974","DOI":"10.1074\/jbc.270.27.15974","article-title":"Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling","volume":"270","author":"OR Colamonici","year":"1995","journal-title":"J Biol Chem"},{"key":"ppat.1009215.ref150","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.virol.2009.11.008","article-title":"Vaccinia virus A35R inhibits MHC class II antigen presentation","volume":"397","author":"KE Rehm","year":"2010","journal-title":"Virology"},{"key":"ppat.1009215.ref151","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1167\/iovs.18-25084","article-title":"The Chemokine Receptor CXCR4 Mediates Recruitment of CD11c+ Conventional Dendritic Cells Into the Inflamed Murine Cornea","volume":"59","author":"MJ Lopez","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ppat.1009215.ref152","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1189\/jlb.0804464","article-title":"CCL5-enhanced human immature dendritic cell migration through the basement membrane in vitro depends on matrix metalloproteinase-9","volume":"79","author":"V Chabot","year":"2006","journal-title":"J Leukoc Biol"},{"key":"ppat.1009215.ref153","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1128\/JVI.01884-08","article-title":"Modified vaccinia virus ankara triggers chemotaxis of monocytes and early respiratory immigration of leukocytes by induction of CCL2 expression","volume":"83","author":"MH Lehmann","year":"2009","journal-title":"J Virol"},{"key":"ppat.1009215.ref154","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1189\/jlb.4MA0815-376RR","article-title":"CCL2 expression is mediated by type I IFN receptor and recruits NK and T cells to the lung during MVA infection","volume":"99","author":"MH Lehmann","year":"2016","journal-title":"J Leukoc Biol"},{"key":"ppat.1009215.ref155","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.3389\/fimmu.2019.01679","article-title":"Early Transcriptional Signature in Dendritic Cells and the Induction of Protective T Cell Responses Upon Immunization With VLPs Containing TLR Ligands-A Role for CCL2.","volume":"10","author":"AC Gomes","year":"2019","journal-title":"Front Immunol."},{"key":"ppat.1009215.ref156","doi-asserted-by":"crossref","first-page":"624","DOI":"10.4049\/jimmunol.160.2.624","article-title":"Blockade of Chemokine Activity by a Soluble Chemokine Binding Protein from Vaccinia Virus","volume":"160","author":"A Alcam\u00ed","year":"1998","journal-title":"Journal of Immunology"},{"key":"ppat.1009215.ref157","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1074\/jbc.M109884200","article-title":"Comprehensive mapping of poxvirus vCCI chemokine-binding protein. Expanded range of ligand interactions and unusual dissociation kinetics","volume":"277","author":"JM Burns","year":"2002","journal-title":"J Biol Chem"},{"key":"ppat.1009215.ref158","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4049\/jimmunol.170.3.1435","article-title":"A soluble chemokine-binding protein from vaccinia virus reduces virus virulence and the inflammatory response to infection","volume":"170","author":"PC Reading","year":"2003","journal-title":"J Immunol"},{"key":"ppat.1009215.ref159","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/jir.2007.0113","article-title":"Vaccinia virus blocks Stat1-dependent and Stat1-independent gene expression induced by type I and type II interferons.","volume":"28","author":"BA Mann","year":"2008","journal-title":"Journal of interferon & cytokine research: the official journal of the International Society for Interferon and Cytokine Research"},{"key":"ppat.1009215.ref160","doi-asserted-by":"crossref","first-page":"e1005955","DOI":"10.1371\/journal.ppat.1005955","article-title":"Vaccinia Virus Protein C6 Inhibits Type I IFN Signalling in the Nucleus and Binds to the Transactivation Domain of STAT2.","volume":"12","author":"JH Stuart","year":"2016","journal-title":"PLOS Pathogens."},{"key":"ppat.1009215.ref161","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.7150\/ijbs.41852","article-title":"STAT4: an immunoregulator contributing to diverse human diseases","volume":"16","author":"C Yang","year":"2020","journal-title":"Int J Biol Sci"},{"key":"ppat.1009215.ref162","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/intimm\/dxw038","article-title":"STAT4 is required for the generation of Th1 and Th2, but not Th17 immune responses during monophosphoryl lipid A adjuvant activity","volume":"28","author":"S Varikuti","year":"2016","journal-title":"Int Immunol"},{"key":"ppat.1009215.ref163","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1038\/s41598-019-40145-0","article-title":"Bacillus Calmette-Guerin Induces PD-L1 Expression on Antigen-Presenting Cells via Autocrine and Paracrine Interleukin-STAT3 Circuits.","volume":"9","author":"A Copland","year":"2019","journal-title":"Sci Rep."},{"key":"ppat.1009215.ref164","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.immuni.2019.06.026","article-title":"Programming of Distinct Chemokine-Dependent and -Independent Search Strategies for Th1 and Th2 Cells Optimizes Function at Inflamed Sites","volume":"51","author":"A Gaylo-Moynihan","year":"2019","journal-title":"Immunity"},{"key":"ppat.1009215.ref165","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ni.2789","article-title":"Molecular signatures of antibody responses derived from a systems biology study of five human vaccines","volume":"15","author":"S Li","year":"2014","journal-title":"Nat Immunol"},{"key":"ppat.1009215.ref166","unstructured":"IMVANEX: European Medicines Agency\u2014Product Information. Upadtes 24\/6\/2020. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/imvanex-epar-product-information_en.pdf."},{"key":"ppat.1009215.ref167","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.vaccine.2019.08.072","article-title":"Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambia-Results of a phase 1\/2 randomized, double-blinded, controlled trial","volume":"38","author":"E Clarke","year":"2020","journal-title":"Vaccine"},{"key":"ppat.1009215.ref168","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1038\/ncomms5447","article-title":"A micro-sterile inflammation array as an adjuvant for influenza vaccines","volume":"5","author":"J Wang","year":"2014","journal-title":"Nat Commun"},{"key":"ppat.1009215.ref169","doi-asserted-by":"crossref","first-page":"457","DOI":"10.7883\/yoken.JJID.2008.457","article-title":"Rate of influenza vaccination and its adverse reactions seen in health care personnel in a single tertiary hospital in Korea.","volume":"61","author":"CS Lee","year":"2008","journal-title":"Jpn J Infect Dis"},{"key":"ppat.1009215.ref170","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fcell.2020.00267","article-title":"Methods for Accurate Assessment of Myofiber Maturity During Skeletal Muscle Regeneration","volume":"8","author":"Y Yoshimoto","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"ppat.1009215.ref171","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3892\/ijmm.2016.2536","article-title":"Myogenic differentiation potential of human tonsil-derived mesenchymal stem cells and their potential for use to promote skeletal muscle regeneration","volume":"37","author":"S Park","year":"2016","journal-title":"Int J Mol Med"},{"key":"ppat.1009215.ref172","doi-asserted-by":"crossref","first-page":"101650","DOI":"10.1016\/j.mcp.2020.101650","article-title":"Isolation and phylogenetic analysis of Getah virus from a commercial modified live vaccine against porcine reproductive and respiratory syndrome virus","volume":"53","author":"F Zhou","year":"2020","journal-title":"Mol Cell Probes"},{"key":"ppat.1009215.ref173","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1080\/21645515.2016.1190489","article-title":"Sepsis, parenteral vaccination and skin disinfection.","volume":"12","author":"IF Cook","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"ppat.1009215.ref174","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/gb-2014-15-3-r46","article-title":"Kraken: ultrafast metagenomic sequence classification using exact alignments","volume":"15","author":"DE Wood","year":"2014","journal-title":"Genome Biol"},{"key":"ppat.1009215.ref175","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1038\/s41598-018-22945-y","article-title":"Mapping the virome in wild-caught Aedes aegypti from Cairns and Bangkok.","volume":"8","author":"M Zakrzewski","year":"2018","journal-title":"Sci Rep."},{"key":"ppat.1009215.ref176","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3390\/pathogens9100848","article-title":"Sequencing of Historical Isolates, K-mer Mining and High Serological Cross-Reactivity with Ross River Virus Argue against the Presence of Getah Virus in Australia.","volume":"9","author":"DJ Rawle","year":"2020","journal-title":"Pathogens"},{"key":"ppat.1009215.ref177","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12864-020-6483-6","article-title":"Virus expression detection reveals RNA-sequencing contamination in TCGA","volume":"21","author":"SR Selitsky","year":"2020","journal-title":"BMC Genomics"},{"key":"ppat.1009215.ref178","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12859-019-2684-x","article-title":"From trash to treasure: detecting unexpected contamination in unmapped NGS data","volume":"20","author":"M Sangiovanni","year":"2019","journal-title":"BMC Bioinformatics"},{"key":"ppat.1009215.ref179","first-page":"78","article-title":"TSG-6: A multifunctional protein with anti-inflammatory and tissue-protective properties","author":"AJ Day","year":"2019","journal-title":"Matrix Biol"},{"key":"ppat.1009215.ref180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molimm.2015.10.018","article-title":"HMGB1 induced inflammatory effect is blocked by CRISPLD2 via MiR155 in hepatic fibrogenesis","volume":"69","author":"H Zhang","year":"2016","journal-title":"Mol Immunol"},{"key":"ppat.1009215.ref181","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41419-020-2237-2","article-title":"Effects of thrombospondin-4 on pro-inflammatory phenotype differentiation and apoptosis in macrophages","volume":"11","author":"MT Rahman","year":"2020","journal-title":"Cell Death Dis."},{"key":"ppat.1009215.ref182","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/nchembio.1105","article-title":"DAGLbeta inhibition perturbs a lipid network involved in macrophage inflammatory responses","volume":"8","author":"KL Hsu","year":"2012","journal-title":"Nat Chem Biol"},{"key":"ppat.1009215.ref183","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s13365-017-0583-3","article-title":"Interferon regulated gene (IRG) expression-signature in a mouse model of chikungunya virus neurovirulence.","volume":"23","author":"SR Nair","year":"2017","journal-title":"J Neurovirol"},{"key":"ppat.1009215.ref184","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/emboj.2008.288","article-title":"Structure of the F-spondin domain of mindin, an integrin ligand and pattern recognition molecule","volume":"28","author":"Y Li","year":"2009","journal-title":"EMBO J"},{"key":"ppat.1009215.ref185","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-genet-120116-024723","article-title":"Mas-Related G Protein-Coupled Receptors and the Biology of Itch Sensation","volume":"51","author":"J Meixiong","year":"2017","journal-title":"Annu Rev Genet"},{"key":"ppat.1009215.ref186","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/mt.2009.182","article-title":"Computational design and application of endogenous promoters for transcriptionally targeted gene therapy for rheumatoid arthritis","volume":"17","author":"J Geurts","year":"2009","journal-title":"Mol Ther"},{"key":"ppat.1009215.ref187","doi-asserted-by":"crossref","first-page":"e1006788","DOI":"10.1371\/journal.ppat.1006788","article-title":"Lower temperatures reduce type I interferon activity and promote alphaviral arthritis.","volume":"13","author":"NA Prow","year":"2017","journal-title":"PLoS Pathog"},{"key":"ppat.1009215.ref188","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.pharmthera.2009.09.005","article-title":"The immunobiology of viral arthritides","volume":"124","author":"A Suhrbier","year":"2009","journal-title":"Pharmacol Ther"},{"key":"ppat.1009215.ref189","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/JLB.3MR0120-390R","article-title":"Eosinophils in wound healing and epithelial remodeling: Is coagulation a missing link?","volume":"108","author":"ME Coden","year":"2020","journal-title":"J Leukoc Biol"},{"key":"ppat.1009215.ref190","doi-asserted-by":"crossref","first-page":"eaat1604","DOI":"10.1126\/sciimmunol.aat1604","article-title":"Type 2 immunity: Expanding our view.","volume":"3","author":"CM Lloyd","year":"2018","journal-title":"Sci Immunol"},{"key":"ppat.1009215.ref191","article-title":"Eosinophil deficiency promotes aberrant repair and adverse remodelling following acute myocardial infarction.","author":"IS Toor","year":"2019","journal-title":"bioRxiv"},{"key":"ppat.1009215.ref192","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/nri.2017.95","article-title":"Functions of tissue-resident eosinophils","volume":"17","author":"PF Weller","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"ppat.1009215.ref193","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cell.2013.02.053","article-title":"Type 2 innate signals stimulate fibro\/adipogenic progenitors to facilitate muscle regeneration","volume":"153","author":"JE Heredia","year":"2013","journal-title":"Cell"},{"key":"ppat.1009215.ref194","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature10339","article-title":"Different patterns of peripheral migration by memory CD4+ and CD8+ T cells","volume":"477","author":"T Gebhardt","year":"2011","journal-title":"Nature"},{"key":"ppat.1009215.ref195","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1096\/fj.09-138057","article-title":"Signal transducer and activator of transcription 1 in T cells plays an indispensable role in immunity to Leishmania major by mediating Th1 cell homing to the site of infection","volume":"23","author":"J Barbi","year":"2009","journal-title":"FASEB J"},{"key":"ppat.1009215.ref196","doi-asserted-by":"crossref","first-page":"e1003472","DOI":"10.1371\/journal.ppat.1003472","article-title":"B cells regulate neutrophilia during Mycobacterium tuberculosis infection and BCG vaccination by modulating the interleukin-17 response.","volume":"9","author":"L Kozakiewicz","year":"2013","journal-title":"PLoS Pathog."},{"key":"ppat.1009215.ref197","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1586\/14760584.2015.966085","article-title":"Vaccine adjuvant uses of poly-IC and derivatives","volume":"14","author":"KA Martins","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"ppat.1009215.ref198","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation.","volume":"20","author":"N Kelley","year":"2019","journal-title":"Int J Mol Sci."},{"key":"ppat.1009215.ref199","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1517\/14712598.6.2.135","article-title":"Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications","volume":"6","author":"GP Pijlman","year":"2006","journal-title":"Expert Opin Biol Ther"},{"key":"ppat.1009215.ref200","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1056\/NEJMcibr2009737","article-title":"Amplifying RNA Vaccine Development","volume":"382","author":"DH Fuller","year":"2020","journal-title":"N Engl J Med"},{"key":"ppat.1009215.ref201","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13045-020-00916-z","article-title":"cGAS-STING, an important pathway in cancer immunotherapy","volume":"13","author":"M Jiang","year":"2020","journal-title":"J Hematol Oncol."},{"key":"ppat.1009215.ref202","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.3389\/fimmu.2019.02274","article-title":"Enhancing Immune Response and Heterosubtypic Protection Ability of Inactivated H7N9 Vaccine by Using STING Agonist as a Mucosal Adjuvant.","volume":"10","author":"J Luo","year":"2019","journal-title":"Front Immunol"},{"key":"ppat.1009215.ref203","doi-asserted-by":"crossref","first-page":"e02145","DOI":"10.1128\/JVI.02145-17","article-title":"Virulent Poxviruses Inhibit DNA Sensing by Preventing STING Activation","volume":"92","author":"I Georgana","year":"2018","journal-title":"J Virol"},{"key":"ppat.1009215.ref204","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41541-019-0132-6","article-title":"The how's and what's of vaccine reactogenicity.","volume":"4","author":"C Herve","year":"2019","journal-title":"NPJ Vaccines"},{"key":"ppat.1009215.ref205","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.4049\/jimmunol.180.8.5402","article-title":"The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells","volume":"180","author":"A Seubert","year":"2008","journal-title":"J Immunol"},{"key":"ppat.1009215.ref206","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3109\/14653249.2010.549123","article-title":"Uptake of antigens from modified vaccinia Ankara virus-infected leukocytes enhances the immunostimulatory capacity of dendritic cells.","volume":"13","author":"C Flechsig","year":"2011","journal-title":"Cytotherapy"},{"key":"ppat.1009215.ref207","doi-asserted-by":"crossref","first-page":"e1008121","DOI":"10.1371\/journal.ppat.1008121","article-title":"ALVAC-HIV B\/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type","volume":"15","author":"L Schifanella","year":"2019","journal-title":"PLoS Pathog"},{"key":"ppat.1009215.ref208","doi-asserted-by":"crossref","first-page":"e0195897","DOI":"10.1371\/journal.pone.0195897","article-title":"Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A randomised, double blind, placebo controlled phase III trial.","volume":"13","author":"ET Overton","year":"2018","journal-title":"PLoS One."},{"key":"ppat.1009215.ref209","doi-asserted-by":"crossref","first-page":"e96031","DOI":"10.1172\/jci.insight.96031","article-title":"Early molecular correlates of adverse events following yellow fever vaccination.","volume":"2","author":"CY Chan","year":"2017","journal-title":"JCI Insight"},{"key":"ppat.1009215.ref210","doi-asserted-by":"crossref","first-page":"e2309","DOI":"10.1371\/journal.pntd.0002309","article-title":"A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection","volume":"7","author":"E Lopez-Gil","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ppat.1009215.ref211","doi-asserted-by":"crossref","first-page":"12102","DOI":"10.1128\/JVI.01190-07","article-title":"Modified Vaccinia Virus Ankara Induces Toll-Like Receptor-Independent Type I Interferon Responses","volume":"81","author":"Z Waibler","year":"2007","journal-title":"Journal of Virology"},{"key":"ppat.1009215.ref212","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10544-019-0412-y","article-title":"A review of microsampling techniques and their social impact","volume":"21","author":"BUW Lei","year":"2019","journal-title":"Biomed Microdevices"},{"key":"ppat.1009215.ref213","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-1-4939-8897-6_10","article-title":"Coculture Method to Obtain Endothelial Networks Within Human Tissue-Engineered Skeletal Muscle.","volume":"1889","author":"D Gholobova","year":"2019","journal-title":"Methods Mol Biol"},{"key":"ppat.1009215.ref214","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/cdd.2015.176","article-title":"Inflammasome-dependent IL-1beta release depends upon membrane permeabilisation","volume":"23","author":"F Martin-Sanchez","year":"2016","journal-title":"Cell Death Differ"},{"key":"ppat.1009215.ref215","doi-asserted-by":"crossref","first-page":"6554","DOI":"10.1128\/JVI.79.10.6554-6559.2005","article-title":"Role of genes that modulate host immune responses in the immunogenicity and pathogenicity of vaccinia virus","volume":"79","author":"SS Jackson","year":"2005","journal-title":"J Virol"},{"key":"ppat.1009215.ref216","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1099\/vir.0.80646-0","article-title":"Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara","volume":"86","author":"C Staib","year":"2005","journal-title":"J Gen Virol"},{"key":"ppat.1009215.ref217","doi-asserted-by":"crossref","first-page":"e1638","DOI":"10.1371\/journal.pone.0001638","article-title":"Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).","volume":"3","author":"MG Cottingham","year":"2008","journal-title":"PLoS One"},{"key":"ppat.1009215.ref218","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1128\/JVI.78.6.2770-2779.2004","article-title":"Induction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes","volume":"78","author":"FA Legrand","year":"2004","journal-title":"J Virol"},{"key":"ppat.1009215.ref219","doi-asserted-by":"crossref","first-page":"eaaw8977","DOI":"10.1126\/science.aaw8977","article-title":"Diverse variola virus (smallpox) strains were widespread in northern Europe in the Viking Age.","volume":"369","author":"B Muhlemann","year":"2020","journal-title":"Science"},{"key":"ppat.1009215.ref220","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1126\/science.abd1214","article-title":"Was smallpox a widespread mild disease?","volume":"369","author":"A Alcami","year":"2020","journal-title":"Science"},{"key":"ppat.1009215.ref221","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.vaccine.2018.01.026","article-title":"Use of ENABL(R) adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine.","volume":"36","author":"J Barrera","year":"2018","journal-title":"Vaccine"},{"key":"ppat.1009215.ref222","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s12026-018-8991-x","article-title":"Matrix-M adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice.","volume":"66","author":"SE Magnusson","year":"2018","journal-title":"Immunol Res"},{"key":"ppat.1009215.ref223","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/vaccines8010064","article-title":"Genetic Adjuvants in Replicating Single-Cycle Adenovirus Vectors Amplify Systemic and Mucosal Immune Responses against HIV-1 Envelope.","volume":"8","author":"WE Matchett","year":"2020","journal-title":"Vaccines (Basel)."},{"key":"ppat.1009215.ref224","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s00262-018-2236-7","article-title":"A phase I\/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma","volume":"67","author":"JE Gray","year":"2018","journal-title":"Cancer Immunol Immunother"},{"key":"ppat.1009215.ref225","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1128\/JVI.02723-13","article-title":"Deletion of the vaccinia virus N2L gene encoding an inhibitor of IRF3 improves the immunogenicity of modified vaccinia virus Ankara expressing HIV-1 antigens","volume":"88","author":"J Garcia-Arriaza","year":"2014","journal-title":"J Virol"},{"key":"ppat.1009215.ref226","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1099\/vir.0.054114-0","article-title":"Vaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence","volume":"94","author":"BJ Ferguson","year":"2013","journal-title":"J Gen Virol"},{"key":"ppat.1009215.ref227","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1001\/archdermatol.2010.46","article-title":"Adverse events following smallpox vaccination with ACAM2000 in a military population","volume":"146","author":"TM Beachkofsky","year":"2010","journal-title":"Arch Dermatol"},{"key":"ppat.1009215.ref228","doi-asserted-by":"crossref","first-page":"307","DOI":"10.18176\/jiaci.0628","article-title":"Exacerbations of severe asthma while on Anti-IL5 biologicals","volume":"30","author":"A Bhalla","year":"2020","journal-title":"J Investig Allergol Clin Immunol"},{"key":"ppat.1009215.ref229","article-title":"The Management of Severe Asthma in 2020","author":"A C\u00f4t\u00e9","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"ppat.1009215.ref230","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1080\/14712598.2020.1782381","article-title":"Anti-IL-5 monoclonal antibodies for the treatment of asthma: an update.","volume":"20","author":"GM Walsh","year":"2020","journal-title":"Expert Opin Biol Ther"},{"key":"ppat.1009215.ref231","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/15058","article-title":"'Hagan D. Advances in vaccine adjuvants","volume":"17","author":"O Singh M","year":"1999","journal-title":"Nat Biotechnol"},{"key":"ppat.1009215.ref232","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.biologicals.2009.02.019","article-title":"A novel vaccine adjuvant for recombinant flu antigens","volume":"37","author":"S Chang","year":"2009","journal-title":"Biologicals"},{"key":"ppat.1009215.ref233","doi-asserted-by":"crossref","first-page":"e2124","DOI":"10.1371\/journal.pntd.0002124","article-title":"Effective chikungunya virus-like particle vaccine produced in insect cells","volume":"7","author":"SW Metz","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ppat.1009215.ref234","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12250-018-0030-5","article-title":"Zika Virus Baculovirus-Expressed Virus-Like Particles Induce Neutralizing Antibodies in Mice.","volume":"33","author":"S Dai","year":"2018","journal-title":"Virol Sin."},{"key":"ppat.1009215.ref235","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.clim.2017.08.004","article-title":"Adjuvant formulations for virus-like particle (VLP) based vaccines.","volume":"183","author":"V Cimica","year":"2017","journal-title":"Clin Immunol"},{"key":"ppat.1009215.ref236","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3390\/vaccines8030368","article-title":"A Yellow Fever Virus 17D Infection and Disease Mouse Model Used to Evaluate a Chimeric Binjari-Yellow Fever Virus Vaccine.","volume":"8","author":"K Yan","year":"2020","journal-title":"Vaccines (Basel)."},{"key":"ppat.1009215.ref237","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1099\/0022-1317-82-9-2083","article-title":"Vaccinia virus semaphorin A39R is a 50\u201355 kDa secreted glycoprotein that affects the outcome of infection in a murine intradermal model","volume":"82","author":"JD Gardner","year":"2001","journal-title":"J Gen Virol"},{"key":"ppat.1009215.ref238","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/viro.1999.0116","article-title":"Vaccinia virus gene B7R encodes an 18-kDa protein that is resident in the endoplasmic reticulum and affects virus virulence","volume":"267","author":"N Price","year":"2000","journal-title":"Virology"},{"key":"ppat.1009215.ref239","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3390\/v2040972","article-title":"Lipid membranes in poxvirus replication.","volume":"2","author":"JP Laliberte","year":"2010","journal-title":"Viruses"},{"key":"ppat.1009215.ref240","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1074\/jbc.M110.198002","article-title":"Envelope lipid-packing as a critical factor for the biological activity and stability of alphavirus particles isolated from mammalian and mosquito cells","volume":"286","author":"IP Sousa","year":"2011","journal-title":"J Biol Chem"},{"key":"ppat.1009215.ref241","doi-asserted-by":"crossref","first-page":"e1006952","DOI":"10.1371\/journal.ppat.1006952","article-title":"Lipids and pathogenic flaviviruses: An intimate union","volume":"14","author":"HC Leier","year":"2018","journal-title":"PLoS Pathog"},{"key":"ppat.1009215.ref242","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/v9090243","article-title":"Regulation of Apoptosis during Flavivirus Infection","volume":"9","author":"T Okamoto","year":"2017","journal-title":"Viruses"},{"key":"ppat.1009215.ref243","doi-asserted-by":"crossref","first-page":"e1006061","DOI":"10.1371\/journal.ppat.1006061","article-title":"Intercellular Extensions Are Induced by the Alphavirus Structural Proteins and Mediate Virus Transmission.","volume":"12","author":"MG Martinez","year":"2016","journal-title":"PLoS Pathog"},{"key":"ppat.1009215.ref244","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/cm.21308","article-title":"Remodeling of the fibroblast cytoskeletal architecture during the replication cycle of Ectromelia virus: A morphological in vitro study in a murine cell line","volume":"73","author":"L Szulc-Dabrowska","year":"2016","journal-title":"Cytoskeleton (Hoboken)."},{"key":"ppat.1009215.ref245","doi-asserted-by":"crossref","first-page":"6784","DOI":"10.1128\/JVI.02705-05","article-title":"Vaccinia virus intermediate and late promoter elements are targeted by the TATA-binding protein","volume":"80","author":"BA Knutson","year":"2006","journal-title":"J Virol"},{"key":"ppat.1009215.ref246","author":"A Simons","year":"2010","journal-title":"FastQC: A quality control tool for high throughput sequence data"},{"key":"ppat.1009215.ref247","first-page":"10","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads.","volume":"17","author":"M Martin","year":"2011","journal-title":"EMBnetjournal"},{"key":"ppat.1009215.ref248","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"A Dobin","year":"2012","journal-title":"Bioinformatics"},{"key":"ppat.1009215.ref249","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1101\/gr.135350.111","article-title":"GENCODE: the reference human genome annotation for The ENCODE Project","volume":"22","author":"J Harrow","year":"2012","journal-title":"Genome Res"},{"key":"ppat.1009215.ref250","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/bioinformatics\/bts196","article-title":"RNA-SeQC: RNA-seq metrics for quality control and process optimization","volume":"28","author":"DS DeLuca","year":"2012","journal-title":"Bioinformatics"},{"key":"ppat.1009215.ref251","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1093\/bioinformatics\/bts356","article-title":"RSeQC: quality control of RNA-seq experiments","volume":"28","author":"L Wang","year":"2012","journal-title":"Bioinformatics"},{"key":"ppat.1009215.ref252","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The Sequence Alignment\/Map format and SAMtools","volume":"25","author":"H Li","year":"2009","journal-title":"Bioinformatics"},{"key":"ppat.1009215.ref253","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/0471250953.bi1112s47","article-title":"BEDTools: The Swiss-Army Tool for Genome Feature Analysis.","volume":"47","author":"AR Quinlan","year":"2014","journal-title":"Curr Protoc Bioinformatics"},{"key":"ppat.1009215.ref254","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13059-019-1891-0","article-title":"Improved metagenomic analysis with Kraken 2","volume":"20","author":"DE Wood","year":"2019","journal-title":"Genome Biol"},{"key":"ppat.1009215.ref255","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1186\/1471-2105-12-385","article-title":"Interactive metagenomic visualization in a Web browser","volume":"12","author":"BD Ondov","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"ppat.1009215.ref256","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"P Shannon","year":"2003","journal-title":"Genome Res"},{"key":"ppat.1009215.ref257","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"D Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"ppat.1009215.ref258","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"A Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1009215.ref259","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ng0506-500","article-title":"GenePattern 2.0.","volume":"38","author":"M Reich","year":"2006","journal-title":"Nat Genet"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1009215","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:00:00Z","timestamp":1611619200000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1009215","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T11:30:42Z","timestamp":1697542242000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1009215"}},"subtitle":[],"editor":[{"given":"Grant","family":"McFadden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":259,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1009215","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.08.17.254938","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,13]]}}}